Skip to main content

Table 6 Diagnostic performance of SNB for axillary staging in 18 F-FDG-positive and AUS-negative patients of category 2

From: Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancer

Patients SUV Involved SNs/resected SNs Involved non-SNs/resected non-SNs Ax dissection
1 8.1 1/1 0/10 Performed
2 2.5 1/1 0/17 Performed
3 2.4 1/2 0/12 Performed
4 1.4 1/3 0/21 performed
5 1.3 4/4 0/12 performed
6 0.7 1/4 0/6 performed
7 1.5 0/1 - not performed
8 1 0/4 - not performed
9 1 0/1 0/1 not performed
10 1 0/4 0/1 not performed
11 0.9 0/1 0/2 not performed
12 0.9 0/4 0/1 not performed
  1. AUS, Axillary ultrasound;SUV, Standardized uptake value; SNs, Sentinel nodes, Ax, Axillary